September 04, 2018
Altimmune Announces Additional Positive Data from Its Phase 2a Study of NasoVAX Intranasal Influenza Vaccine
Media
September 03, 2018
Nexstim Plc reports results of the supplementary Phase III E-FIT trial
August 31, 2018
Altimmune Announces Initial Single-Dose Data from Its NasoShield Phase 1 Study
August 30, 2018
Carl-Johan Dalsgaard Appointed New CEO of Vicore Pharma
August 28, 2018
Strongbridge Biopharma plc Announces Presentations at Two Upcoming Investor Conferences
August 24, 2018
Save the date: BONESUPPORT Capital Markets Days to be held in Stockholm and London
August 24, 2018
Interim report April-June 2018
August 23, 2018
Targovax ASA: Second quarter and first half year 2018 results
August 22, 2018
Nordic Nanovector ASA: Results for the Second Quarter and First Half 2018
August 20, 2018
Vicore Pharmas acquisition of INIM Pharma completed
